Wang, K.Y.; Heikal, O.S.; van Rheenen, P.F.; Touw, D.J.; Bourgonje, A.R.; Mian, P.
Clinical and Biochemical Factors Associated with Infliximab Pharmacokinetics in Paediatric Patients with Inflammatory Bowel Disease. J. Clin. Med. 2025, 14, 845.
https://doi.org/10.3390/jcm14030845
AMA Style
Wang KY, Heikal OS, van Rheenen PF, Touw DJ, Bourgonje AR, Mian P.
Clinical and Biochemical Factors Associated with Infliximab Pharmacokinetics in Paediatric Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine. 2025; 14(3):845.
https://doi.org/10.3390/jcm14030845
Chicago/Turabian Style
Wang, Ka Yu, Omnia Salah Heikal, Patrick F. van Rheenen, Daan J. Touw, Arno R. Bourgonje, and Paola Mian.
2025. "Clinical and Biochemical Factors Associated with Infliximab Pharmacokinetics in Paediatric Patients with Inflammatory Bowel Disease" Journal of Clinical Medicine 14, no. 3: 845.
https://doi.org/10.3390/jcm14030845
APA Style
Wang, K. Y., Heikal, O. S., van Rheenen, P. F., Touw, D. J., Bourgonje, A. R., & Mian, P.
(2025). Clinical and Biochemical Factors Associated with Infliximab Pharmacokinetics in Paediatric Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine, 14(3), 845.
https://doi.org/10.3390/jcm14030845